[ad_1]
Coronavirus: The world has yet to find an effective cure for COVID-19
New Delhi:
India is working on four traditional medicine formulations to treat coronavirus infection and trials will start soon, the country’s AYUSH minister tweeted. AYUSH or short for ayurveda, yoga, unani, siddha, and homeopathy is the country’s traditional medicine ministry.
“@Moayush and @CSIR_IND are working together to validate four Ayush formulations against # COVID19Pandemic and trials will begin within a week. These formulations will be tested as additional therapy and standard care for COVID-19 patients.” AYUSH Minister of State Shripad Y Naik tweeted.
The Scientific and Industrial Research Council or CSIR, with which the AYUSH Ministry is working to carry out traditional medicine trials, is one of the largest and most diversified scientific and industrial research organizations in the world.
“I am confident and very hopeful that our traditional medicinal system will show the way to overcome these pandemics,” Naik tweeted.
the @moayush & the @CSIR_IND are working together to validate four Ayush formulations against #COVID-19 pandemic and testing will begin in a week. These formulations will be tested as complementary therapy and standard care for COVID-19 patients.
– Shripad Y. Naik (@shripadynaik) May 14, 2020
Doctors are testing a combination treatment for the new coronavirus, a virus that has never been seen before and whose characteristics are still being studied, until the time that a large number of vaccines are developed, tested and produced.
Ayurveda or not, so far the world has not found a cure for coronavirus that is fully endorsed by researchers and drug manufacturers unanimously. Traces of different drugs follow.
Plasma therapy, which involves taking antibody-rich plasma from the blood of a recovered COVID-19 patient, has been said by some medical experts to help infected people fight the virus. But this treatment is also not 100% backed by scientists, as its effectiveness is inconclusive.
A rapid coronavirus test promoted by United States President Donald Trump, and used to evaluate White House officials, produces false negatives in almost half of cases, according to a new study by NYU Langone researchers. Health, the AFP news agency reported. This matter is one of many examples of the difficulties faced by those trying to manufacture a vaccine for the highly infectious virus.
Gilead’s antiviral drug remdesivir in May received emergency use authorization from the U.S. Food and Drug Administration to treat patients with COVID-19. With no other approved treatment for COVID-19, interest in remdesivir has been growing, and the company is being closely watched for the price and distribution of the limited supply of the drug.
.
[ad_2]
